Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing multicenter observational safety study of dorzagliatin in type 2 diabetes mellitus
CTR20233169Phase 4Completed
- Sponsor
- Hua Medicine
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dorzagliatin in type 2 diabetes mellitus (T2DM), sponsored by Hua Medicine. Started Oct 2023; status: completed.
02
Drugs
dorzagliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20233169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233169.